Home › Metastatic Cancer › Texas › Sugar Land
Metastatic Cancer clinical trials in Sugar Land, TX
4 studies for Metastatic Cancer are looking for participants at sites in and around Sugar Land (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Texas Oncology - Gulf Coast, Sugar Land
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Kelsey-Seybold Clinic - Fort Bend Campus, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecruitingPhase 3
- Research Site, Sugar Land
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- The University of Texas, MD Anderson Cancer Center - Sugar Land, Sugar Land
- Texas Oncology - Gulf Coast, Sugar Land
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Sugar Land
- Obesity11 studies
- Overweight10 studies
- Non-Small Cell Lung Cancer8 studies
- Breast Cancer7 studies
- Disorders of Excessive Somnolence7 studies
- Steatotic Liver Disease6 studies
- Lung Cancer6 studies
- Atopic Dermatitis (Eczema)6 studies
- Type 2 Diabetes5 studies
- Sleep Disorders5 studies
- Prostate Cancer4 studies
- Pneumococcal Infections4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.